Lilly eying deal with Turkish drug company
Eli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, sources say.
Health Care & Life Sciences
Articles
Community agrees to absorb Howard Regional
Kokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than four months after it broke off a merger deal with Indiana University Health.
Lilly’s quarterly profit tumbles, but tops Wall Street estimates
Patent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected sales of other products.
Symmetry Ex-CEO Moore to return $450,000 in clawback suit
Symmetry Medical Inc.’s former CEO will return $450,000 in pay and stock proceeds to resolve U.S. Securities and Exchange Commission claims that he profited from accounting fraud by a United Kingdom unit.
Purdue hopes center simplifies commercialization
Purdue University’s new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help developing their research into products and for outside investors to find out what research is taking place there.
Gallagher sees more broker mergers coming
The Carmel office of Arthur J. Gallagher & Co. just made its sixth acquisition in five years, and it expects looming changes to tax and health laws to produce even more chances to snap up benefits brokers this year.
Lilly’s ex-partner wins FDA approval for diabetes drug
Amylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly and Co. co-developed the drug, but ended its partnership with Amylin last year.
Indiana House backs break for bars on smoking ban
The Indiana House has added an 18-month exemption for bars to a bill calling for a broad statewide smoking ban.
UPDATE: WellPoint to boost primary-care pay
Health insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn’t currently cover, changes that could give patients more quality time with their doctors.
Indiana House backs broader ban on synthetic drugs
The Indiana House has approved a bill that would broaden the state's ban on synthetic drugs to include compounds nicknamed "bath salts" and others that mimic marijuana.
Indiana Senate panel backs limits on abortion pill
The Senate health committee voted 5-4 in support of the bill that requires that a doctor examine a woman in person before giving her RU-486, provide written information about the physical risks of abortion and to schedule a follow-up ultrasound.
WellPoint shares sink after disappointing earnings report
WellPoint Inc.'s stock price dropped almost 5 percent Wednesday after the insurer's fourth-quarter earnings failed to meet analyst expectations.
WellPoint earnings fall well short of analysts’ expectations
The Indianapolis-based health insurer reported earnings of $335.3 million, or 96 cents per share, down 39 percent from the same quarter a year ago.
Eli Lilly unit plans to buy feed-enzyme maker
Drugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products that improve poultry, egg and meat production.
Poll: Anthem so-so in customer satisfaction
Anthem Blue Cross and Blue Shield ranked No. 12 in a new national customer satisfaction survey, but the poor showing doesn’t appear to threaten the Indianapolis-based company’s business success.<
Walgreen marks retailers’ push into health care
Health care reform is projected to cover 30 million more people with health insurance—and overwhelm the nation’s doctors. That’s why retailers like Walgreen and Wal-Mart are moving into the space in a big way.
Deal with Walgreen perplexes Arcadia’s investors
Something doesn’t add up about Arcadia Resources Inc.’s agreement to sell its pharmacy business for a low price of $2 million, according to many of the Indianapolis company’s investors.
French breast-implant recall could sway U.S. device debate
U.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
Indiana deals ranged upward of $800 million
Mergers and acquisitions in 2011 ranged from WellPoint’s acquisition of CareMore to a trucking company merger.
City set to cancel tax abatement for medical device firm
Polymer Technology Systems said in 2007 that it would make a $3 million investment at its operation on Zionsville Road and create 110 jobs.